Compare NTNX & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTNX | COO |
|---|---|---|
| Founded | 2009 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.7B |
| IPO Year | 2015 | 1994 |
| Metric | NTNX | COO |
|---|---|---|
| Price | $55.04 | $70.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 11 |
| Target Price | $62.29 | ★ $90.18 |
| AVG Volume (30 Days) | ★ 3.3M | 2.4M |
| Earning Date | 05-27-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 227.45 | N/A |
| EPS | ★ 0.82 | 0.27 |
| Revenue | ★ $2,537,927,000.00 | $2,532,800,000.00 |
| Revenue This Year | $13.44 | $6.66 |
| Revenue Next Year | $13.03 | $5.18 |
| P/E Ratio | ★ $64.18 | $260.11 |
| Revenue Growth | 18.11 | ★ 18.41 |
| 52 Week Low | $34.01 | $58.89 |
| 52 Week High | $82.42 | $89.83 |
| Indicator | NTNX | COO |
|---|---|---|
| Relative Strength Index (RSI) | 58.45 | 52.73 |
| Support Level | $44.85 | $68.09 |
| Resistance Level | $58.65 | $73.39 |
| Average True Range (ATR) | 2.30 | 1.71 |
| MACD | -0.25 | -0.35 |
| Stochastic Oscillator | 39.83 | 37.08 |
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.